October 28, 2022
In animal models, UC San Diego researchers found that intensive physical therapy in tandem with implanted neural stem cells increased tissue growth, repair and functionality in spinal cord injuries more than those treatments alone.
November 21, 2022
UC San Diego Alpha Stem Cell Clinic awarded $8M to expand clinical trials of novel stem cell therapies. The CIRM award will advance partnerships between academic and industry experts in San Diego to expedite clinical trials for patients with difficult-to-treat diseases.
September 28, 2020
A team of researchers in the United States and Japan reports that spinal cord stimulation (SCS) measurably decreased pain and reduced motor symptoms of Parkinson’s disease, both as a singular therapy and as a “salvage therapy” after deep brain stimulation (DBS) therapies were ineffective.
September 19, 2022
A multidisciplinary team led by researchers at UC San Diego has received $1.2 million from the National Science Foundation (NSF) to create a novel system to study and inform the treatment of chronic low back pain.
December 12, 2023
Jacobs School of Engineering professors Eric Fullerton and Prashant Mali have been named 2023 Fellows of the National Academy of Inventors. The distinction honors academic inventors whose work has made a tangible impact on the quality of life, economic development, and the welfare of society.
January 28, 2021
…Trials Investigating Convalescent Plasma Therapy for COVID-19 It’s hoped the long-used approach, which would use antibody-rich infusions, can either reduce disease symptoms or prevent infections after exposure to SARS-CoV-2 Parallel to COVID-19 vaccination efforts, physicians and researchers at UC San Diego Health, with collaborators across the country, are conducting a…
June 3, 2021
As the first designated medical center in San Diego certified to offer this type of immunotherapy, UC San Diego Health will begin treating patients this month.
July 25, 2023
UC San Diego Health offers new minimally invasive sports medicine treatment to repair tendon overuse injuries.
May 5, 2014
With accelerating development of personalized cancer treatments matched to a patient’s DNA sequencing, proponents say frontline physicians increasingly need help to maneuver through the complex genomic landscape to find the most effective, individualized therapy.
December 3, 2018
Following the FDA’s approval of chimeric antigen receptor (CAR) T-cell therapies for the treatment of certain types of non-Hodgkin lymphomas, UC San Diego Health was the first medical center in San Diego to be certified to offer this type of immunotherapy outside of a clinical trial.
